Department of Biomedical Sciences, University of Padua, Padua, Italy.
Neuroscience Institute - Italian National Research Council (CNR), Padua, Italy.
Autophagy. 2019 Dec;15(12):2044-2062. doi: 10.1080/15548627.2019.1596489. Epub 2019 Mar 27.
PSEN2 (presenilin 2) is one of the 3 proteins that, when mutated, causes early onset familial Alzheimer disease (FAD) cases. In addition to its well-known role within the γ-secretase complex (the enzyme ultimately responsible for Aβ peptides formation), PSEN2 is endowed with some γ-secretase-independent functions in distinct cell signaling pathways, such as the modulation of intracellular Ca homeostasis. Here, by using different FAD-PSEN2 cell models, we demonstrate that mutated PSEN2 impairs autophagy by causing a block in the degradative flux at the level of the autophagosome-lysosome fusion step. The defect does not depend on an altered lysosomal functionality but rather on a decreased recruitment of the small GTPase RAB7 to autophagosomes, a key event for normal autophagy progression. Importantly, FAD-PSEN2 action on autophagy is unrelated to its γ-secretase activity but depends on its previously reported ability to partially deplete ER Ca content, thus reducing cytosolic Ca response upon IP3-linked cell stimulations. Our data sustain the pivotal role for Ca signaling in autophagy and reveal a novel mechanism by which FAD-linked presenilins alter the degradative process, reinforcing the view of a causative role for a dysfunctional quality control pathway in AD neurodegeneration. Aβ: amyloid β; AD: Alzheimer disease; ACTB: actin beta; AMPK: AMP-activated protein kinase; APP: amyloid-beta precursor protein; BafA: bafilomycin A; BAPTA-AM: 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester; CFP: cyan fluorescent protein; EGTA-AM: ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid acetoxymethyl ester; ER: endoplasmic reticulum; EGFP-HDQ74: enhanced GFP-huntingtin exon 1 containing 74 polyglutamine repeats; FAD: familial Alzheimer disease; FCS: fetal calf serum; FRET: fluorescence/Förster resonance energy transfer; GFP: green fluorescent protein; IP3: inositol trisphosphate; KD: knockdown; LAMP1: lysosomal associated membrane protein 1; MAP1LC3-II/LC3-II: lipidated microtubule-associated protein 1 light chain 3; MCU: mitochondrial calcium uniporter; MICU1: mitochondrial calcium uptake 1; MEFs: mouse embryonic fibroblasts; MFN2: mitofusin 2; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; SQSTM1/p62: sequestosome 1; PSEN1: presenilin 1; PSEN2: presenilin 2; RAB7: RAB7A: member RAS oncogene family; RFP: red fluorescent protein; ATP2A/SERCA: ATPase sarcoplasmic/endoplasmic reticulum Ca transporting; siRNA: small interference RNA; V-ATPase: vacuolar-type H-ATPase; WT: wild type.
PSEN2(早老素 2)是导致早发性家族性阿尔茨海默病(FAD)病例的 3 种突变蛋白之一。除了在 γ-分泌酶复合物(最终负责形成 Aβ 肽的酶)中众所周知的作用外,PSEN2 在不同的细胞信号通路中还具有一些 γ-分泌酶独立的功能,例如调节细胞内 Ca 稳态。在这里,我们使用不同的 FAD-PSEN2 细胞模型证明,突变的 PSEN2 通过在自噬体-溶酶体融合步骤引起降解通量的阻断来破坏自噬。该缺陷不依赖于溶酶体功能的改变,而是依赖于小 GTPase RAB7 向自噬体的募集减少,这是正常自噬进展的关键事件。重要的是,FAD-PSEN2 对自噬的作用与其 γ-分泌酶活性无关,而是依赖于其先前报道的部分耗尽内质网 Ca 含量的能力,从而减少 IP3 连接的细胞刺激后的细胞溶质 Ca 反应。我们的数据支持 Ca 信号在自噬中的关键作用,并揭示了 FAD 相关早老素改变降解过程的新机制,这增强了功能失调的质量控制途径在 AD 神经退行性变中的因果作用的观点。Aβ:淀粉样 β;AD:阿尔茨海默病;ACTB:肌动蛋白 β;AMPK:AMP 激活的蛋白激酶;APP:淀粉样-β前体蛋白;BafA:巴弗霉素 A;BAPTA-AM:1,2-双(邻氨基苯氧基)乙烷-N,N,N',N'-四乙酸乙二胺盐;CFP:青色荧光蛋白;EGTA-AM:乙二醇双(β-氨基乙基醚)-N,N,N',N'-四乙酸乙二胺盐;ER:内质网;EGFPHDQ74:增强 GFP-亨廷顿外显子 1 含有 74 个多聚谷氨酰胺重复;FAD:家族性阿尔茨海默病;FCS:胎牛血清;FRET:荧光/福斯特共振能量转移;GFP:绿色荧光蛋白;IP3:肌醇三磷酸;KD:敲低;LAMP1:溶酶体相关膜蛋白 1;MAP1LC3-II/LC3-II:脂化微管相关蛋白 1 轻链 3;MCU:线粒体钙单向转运体;MICU1:线粒体钙摄取 1;MEFs:小鼠胚胎成纤维细胞;MFN2:线粒体融合蛋白 2;MTOR:雷帕霉素靶蛋白激酶;MTORC1:雷帕霉素靶蛋白复合物 1;SQSTM1/p62:自噬体 1;PSEN1:早老素 1;PSEN2:早老素 2;RAB7:RAB7A:RAS 癌基因家族成员;RFP:红色荧光蛋白;ATP2A/SERCA:肌浆/内质网 Ca 转运的 ATP 酶;siRNA:小干扰 RNA;V-ATPase:液泡型 H+-ATP 酶;WT:野生型。